Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Drug DescriptionSide Effects & Drug InteractionsWarnings & Precautions
Clinical PharmacologyOverdosage & ContraindicationsIndications & DosagePatient Info

Nexium

[Esomeprazole]

Special Populations Geriatric:

Text Continues Below



No dosage adjustment is necessary. (See CLINICAL PHARMACOLOGY, Pharmacokinetics.)

Renal Insufficiency:

No dosage adjustment is necessary. (See CLINICAL PHARMACOLOGY, Pharmacokinetics.)

Hepatic Insufficiency:

No dosage adjustment is necessary in patients with mild to moderate liver impairment (Child Pugh Classes A and B). For patients with severe liver impairment (Child Pugh Class C), a dose of 20 mg of NEXIUM should not be exceeded (See CLINICAL PHARMACOLOGY, Pharmacokinetics.)

Gender:

No dosage adjustment is necessary. (See CLINICAL PHARMACOLOGY, Pharmacokinetics.)

HOW SUPPLIED

NEXIUM Delayed-Release Capsules, 20 mg, are opaque, hard gelatin, amethyst colored capsules with two radial bars in yellow on the cap and 20 mg in yellow on the body. They are supplied as follows:
NDC 0186-5020-31 unit of use bottles of 30 NDC 0186-5022-28 unit dose packages of 100

NDC 0186-5020-54 bottles of 90 NDC 0186-5020-82 bottles of 1000

NEXIUM Delayed-Release Capsules, 40 mg, are opaque, hard gelatin, amethyst colored capsules with three radial bars in yellow on the cap and 40 mg in yellow on the body. They are supplied as follows:
NDC 0186-5040-31 unit of use bottles of 30 NDC 0186-5042-28 unit dose packages of 100

NDC 0186-5040-54 bottles of 90 NDC 0186-5040-82 bottles of 1000

Storage Store at 25° C (77° F); excursions permitted to 15Š 30° C (59Š 86° F).
[See USP Controlled Room Temperature]. Keep container tightly closed. Dispense in a tight container if the product package is subdivided.
REFERENCES
1. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow

Aerobically. Fifth Edition: Approved Standard NCCLS Document M7-A5, Vol. 20, no. 2, NCCLS, Wayne, PA, January 2000.

NEXIUM is a trademark of the AstraZeneca group ©AstraZeneca 2003
Manufactured for: AstraZeneca LP
Wilmington, DE 19850 By: AstraZeneca AB
Södertälje, Sweden

Product of France
620514-04 9346604
Rev. 03/ 03

Nexium ® (esomeprazole magnesium) Delayed-Release Capsules Nexium ® (esomeprazole magnesium) Delayed-Release Capsules Nexium ® (esomeprazole magnesium) Delayed-Release Capsules

Page:  << Prev | 1 | 2








We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map